LSDI - Lucy Scientific Discovery, Inc.


0.5139
-0.156   -30.356%

Share volume: 314,509
Last Updated: 06-28-2024

PREVIOUS CLOSE
CHG
CHG%

$0.67
-0.16
-23.29%
This ticker is disabled and data are no longer maintained and up to date.
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.51
P/E Ratio 
0.00
DAY RANGE
$0.48 - $0.67
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
1.765 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Christopher McElvany
Region: US
Website: www.lucyscientific.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

We are an early-stage psychotropics contract manufacturing company focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. We were incorporated under the laws of British Columbia, Canada on February 17, 2017 under the name Hollyweed North Cannabis, Inc. On May 18, 2021, we changed our name to Lucy Scientific Discovery Inc. We have two active wholly owned subsidiaries, TerraCube International Inc., or TerraCube, and LSDI Manufacturing Inc. Our principal executive offices are located at 301-1321 Blanshard Street, Victoria, British Columbia Canada.

Recent news